A Randomized, Open-Label Phase II/III Efficacy and Safety Study of Atezolizumab in Combination with FLOT Versus FLOT Alone in Patients with Gastric Cancer and Adenocarcinoma of the Oesophagogastric Junction and High Immune Responsiveness: the IKF633/DANTE Trial, a Trial of AIO in Collaboration with SAKK.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined